TERNS PHARMACEUTICALS INC's ticker is TERN and the CUSIP is 880881107. A total of 127 filers reported holding TERNS PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $100,394 | – | 15,469 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 2,675,133 | $58,853,000 | 2.07% |
| Samsara BioCapital, LLC | 497,555 | $10,946,000 | 2.02% |
| Antara Capital LP | 751,813 | $16,275,000 | 1.37% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,345,959 | $51,611,000 | 1.08% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,071,421 | $23,571,000 | 0.98% |
| Orbimed Advisors | 3,791,204 | $83,406,000 | 0.78% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,125,136 | $24,753,000 | 0.37% |
| Avidity Partners Management LP | 400,000 | $8,800,000 | 0.24% |
| PFM Health Sciences, LP | 329,274 | $7,244,000 | 0.22% |
| SPHERA FUNDS MANAGEMENT LTD. | 70,000 | $1,540,000 | 0.12% |